Report Detail

Other Global Cryopreserved Human Hepatocytes Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4534280
  • |
  • 09 June, 2023
  • |
  • Global
  • |
  • 103 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

According to our (Global Info Research) latest study, the global Cryopreserved Human Hepatocytes market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Cryopreserved hepatocytes as an in vitro tool for generating physiologically relevant results
This report is a detailed and comprehensive analysis for global Cryopreserved Human Hepatocytes market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cryopreserved Human Hepatocytes market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cryopreserved Human Hepatocytes market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cryopreserved Human Hepatocytes market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cryopreserved Human Hepatocytes market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cryopreserved Human Hepatocytes
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cryopreserved Human Hepatocytes market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Corning, Thermo Fisher Scientific, Tocris Bioscience, LONZA and Cytes Biotechnologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Cryopreserved Human Hepatocytes market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Normal Cells
Diseased Cells
Market segment by Application
Cell/Molecular Biology
Virology
Other
Major players covered
Corning
Thermo Fisher Scientific
Tocris Bioscience
LONZA
Cytes Biotechnologies
BioIVT
XenoTech
Sunncell
Atlantis Bioscience Pte Ltd
PRIMACYT Cell Culture Technology GmbH
Discovery
MB Biosciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cryopreserved Human Hepatocytes product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cryopreserved Human Hepatocytes, with price, sales, revenue and global market share of Cryopreserved Human Hepatocytes from 2018 to 2023.
Chapter 3, the Cryopreserved Human Hepatocytes competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cryopreserved Human Hepatocytes breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cryopreserved Human Hepatocytes market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cryopreserved Human Hepatocytes.
Chapter 14 and 15, to describe Cryopreserved Human Hepatocytes sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cryopreserved Human Hepatocytes
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cryopreserved Human Hepatocytes Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Normal Cells
    • 1.3.3 Diseased Cells
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cryopreserved Human Hepatocytes Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Cell/Molecular Biology
    • 1.4.3 Virology
    • 1.4.4 Other
  • 1.5 Global Cryopreserved Human Hepatocytes Market Size & Forecast
    • 1.5.1 Global Cryopreserved Human Hepatocytes Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Cryopreserved Human Hepatocytes Sales Quantity (2018-2029)
    • 1.5.3 Global Cryopreserved Human Hepatocytes Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Corning
    • 2.1.1 Corning Details
    • 2.1.2 Corning Major Business
    • 2.1.3 Corning Cryopreserved Human Hepatocytes Product and Services
    • 2.1.4 Corning Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Corning Recent Developments/Updates
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Cryopreserved Human Hepatocytes Product and Services
    • 2.2.4 Thermo Fisher Scientific Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.3 Tocris Bioscience
    • 2.3.1 Tocris Bioscience Details
    • 2.3.2 Tocris Bioscience Major Business
    • 2.3.3 Tocris Bioscience Cryopreserved Human Hepatocytes Product and Services
    • 2.3.4 Tocris Bioscience Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Tocris Bioscience Recent Developments/Updates
  • 2.4 LONZA
    • 2.4.1 LONZA Details
    • 2.4.2 LONZA Major Business
    • 2.4.3 LONZA Cryopreserved Human Hepatocytes Product and Services
    • 2.4.4 LONZA Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 LONZA Recent Developments/Updates
  • 2.5 Cytes Biotechnologies
    • 2.5.1 Cytes Biotechnologies Details
    • 2.5.2 Cytes Biotechnologies Major Business
    • 2.5.3 Cytes Biotechnologies Cryopreserved Human Hepatocytes Product and Services
    • 2.5.4 Cytes Biotechnologies Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Cytes Biotechnologies Recent Developments/Updates
  • 2.6 BioIVT
    • 2.6.1 BioIVT Details
    • 2.6.2 BioIVT Major Business
    • 2.6.3 BioIVT Cryopreserved Human Hepatocytes Product and Services
    • 2.6.4 BioIVT Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 BioIVT Recent Developments/Updates
  • 2.7 XenoTech
    • 2.7.1 XenoTech Details
    • 2.7.2 XenoTech Major Business
    • 2.7.3 XenoTech Cryopreserved Human Hepatocytes Product and Services
    • 2.7.4 XenoTech Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 XenoTech Recent Developments/Updates
  • 2.8 Sunncell
    • 2.8.1 Sunncell Details
    • 2.8.2 Sunncell Major Business
    • 2.8.3 Sunncell Cryopreserved Human Hepatocytes Product and Services
    • 2.8.4 Sunncell Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Sunncell Recent Developments/Updates
  • 2.9 Atlantis Bioscience Pte Ltd
    • 2.9.1 Atlantis Bioscience Pte Ltd Details
    • 2.9.2 Atlantis Bioscience Pte Ltd Major Business
    • 2.9.3 Atlantis Bioscience Pte Ltd Cryopreserved Human Hepatocytes Product and Services
    • 2.9.4 Atlantis Bioscience Pte Ltd Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Atlantis Bioscience Pte Ltd Recent Developments/Updates
  • 2.10 PRIMACYT Cell Culture Technology GmbH
    • 2.10.1 PRIMACYT Cell Culture Technology GmbH Details
    • 2.10.2 PRIMACYT Cell Culture Technology GmbH Major Business
    • 2.10.3 PRIMACYT Cell Culture Technology GmbH Cryopreserved Human Hepatocytes Product and Services
    • 2.10.4 PRIMACYT Cell Culture Technology GmbH Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 PRIMACYT Cell Culture Technology GmbH Recent Developments/Updates
  • 2.11 Discovery
    • 2.11.1 Discovery Details
    • 2.11.2 Discovery Major Business
    • 2.11.3 Discovery Cryopreserved Human Hepatocytes Product and Services
    • 2.11.4 Discovery Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Discovery Recent Developments/Updates
  • 2.12 MB Biosciences
    • 2.12.1 MB Biosciences Details
    • 2.12.2 MB Biosciences Major Business
    • 2.12.3 MB Biosciences Cryopreserved Human Hepatocytes Product and Services
    • 2.12.4 MB Biosciences Cryopreserved Human Hepatocytes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 MB Biosciences Recent Developments/Updates

3 Competitive Environment: Cryopreserved Human Hepatocytes by Manufacturer

  • 3.1 Global Cryopreserved Human Hepatocytes Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Cryopreserved Human Hepatocytes Revenue by Manufacturer (2018-2023)
  • 3.3 Global Cryopreserved Human Hepatocytes Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Cryopreserved Human Hepatocytes by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Cryopreserved Human Hepatocytes Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Cryopreserved Human Hepatocytes Manufacturer Market Share in 2022
  • 3.5 Cryopreserved Human Hepatocytes Market: Overall Company Footprint Analysis
    • 3.5.1 Cryopreserved Human Hepatocytes Market: Region Footprint
    • 3.5.2 Cryopreserved Human Hepatocytes Market: Company Product Type Footprint
    • 3.5.3 Cryopreserved Human Hepatocytes Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cryopreserved Human Hepatocytes Market Size by Region
    • 4.1.1 Global Cryopreserved Human Hepatocytes Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Cryopreserved Human Hepatocytes Consumption Value by Region (2018-2029)
    • 4.1.3 Global Cryopreserved Human Hepatocytes Average Price by Region (2018-2029)
  • 4.2 North America Cryopreserved Human Hepatocytes Consumption Value (2018-2029)
  • 4.3 Europe Cryopreserved Human Hepatocytes Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Cryopreserved Human Hepatocytes Consumption Value (2018-2029)
  • 4.5 South America Cryopreserved Human Hepatocytes Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Cryopreserved Human Hepatocytes Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Cryopreserved Human Hepatocytes Sales Quantity by Type (2018-2029)
  • 5.2 Global Cryopreserved Human Hepatocytes Consumption Value by Type (2018-2029)
  • 5.3 Global Cryopreserved Human Hepatocytes Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Cryopreserved Human Hepatocytes Sales Quantity by Application (2018-2029)
  • 6.2 Global Cryopreserved Human Hepatocytes Consumption Value by Application (2018-2029)
  • 6.3 Global Cryopreserved Human Hepatocytes Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Cryopreserved Human Hepatocytes Sales Quantity by Type (2018-2029)
  • 7.2 North America Cryopreserved Human Hepatocytes Sales Quantity by Application (2018-2029)
  • 7.3 North America Cryopreserved Human Hepatocytes Market Size by Country
    • 7.3.1 North America Cryopreserved Human Hepatocytes Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Cryopreserved Human Hepatocytes Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Cryopreserved Human Hepatocytes Sales Quantity by Type (2018-2029)
  • 8.2 Europe Cryopreserved Human Hepatocytes Sales Quantity by Application (2018-2029)
  • 8.3 Europe Cryopreserved Human Hepatocytes Market Size by Country
    • 8.3.1 Europe Cryopreserved Human Hepatocytes Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Cryopreserved Human Hepatocytes Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cryopreserved Human Hepatocytes Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Cryopreserved Human Hepatocytes Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Cryopreserved Human Hepatocytes Market Size by Region
    • 9.3.1 Asia-Pacific Cryopreserved Human Hepatocytes Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Cryopreserved Human Hepatocytes Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Cryopreserved Human Hepatocytes Sales Quantity by Type (2018-2029)
  • 10.2 South America Cryopreserved Human Hepatocytes Sales Quantity by Application (2018-2029)
  • 10.3 South America Cryopreserved Human Hepatocytes Market Size by Country
    • 10.3.1 South America Cryopreserved Human Hepatocytes Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Cryopreserved Human Hepatocytes Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cryopreserved Human Hepatocytes Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Cryopreserved Human Hepatocytes Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Cryopreserved Human Hepatocytes Market Size by Country
    • 11.3.1 Middle East & Africa Cryopreserved Human Hepatocytes Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Cryopreserved Human Hepatocytes Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Cryopreserved Human Hepatocytes Market Drivers
  • 12.2 Cryopreserved Human Hepatocytes Market Restraints
  • 12.3 Cryopreserved Human Hepatocytes Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cryopreserved Human Hepatocytes and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cryopreserved Human Hepatocytes
  • 13.3 Cryopreserved Human Hepatocytes Production Process
  • 13.4 Cryopreserved Human Hepatocytes Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cryopreserved Human Hepatocytes Typical Distributors
  • 14.3 Cryopreserved Human Hepatocytes Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cryopreserved Human Hepatocytes. Industry analysis & Market Report on Cryopreserved Human Hepatocytes is a syndicated market report, published as Global Cryopreserved Human Hepatocytes Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Cryopreserved Human Hepatocytes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,735.28
    4,102.92
    5,470.56
    3,208.56
    4,812.84
    6,417.12
    547,021.20
    820,531.80
    1,094,042.40
    290,336.40
    435,504.60
    580,672.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report